-transparent.png){kind=logo}
Immunization procedures with live attenuated and inactivated vaccines were carried out on a group of young recruits at the beginning of an outbreak of infection due to an A/Victoria/3/75-related virus strain, which occurred in February 1977 in a military camp. A retrospective investigation on protection from clinical influenza was then performed in order to investigate whether immunization with live virus vaccines, administered at the beginning of an epidemic, could provide early protection from the disease. In the course of the two weeks following vaccination, laboratory-confirmed clinical influenza cases occurred in 4 subjects among the 110 volunteers of the control group which received placebo, and in 8, 7 and 4 subjects respectively of the 3 groups of about 125 individuals, each of which received one of the following vaccine preparations: (a), live attenuated A/Victoria/3/75 influenza virus oral vaccine, grown on chick embryo kidney culture; (b), live attenuated nasal vaccine, a recombinant of A/Puerto Rico/8/34 with A/Victoria/3/75 virus; and (c), inactivated A/Victoria/3/75 virus intramuscular vaccine. These data do not support the hypothesis that, during an epidemic of infection, early protection from clinical influenza can be achieved through immunization with live attenuated or inactivated influenza virus vaccines, in spite of the high immunizing capability of the vaccine preparations.
G Rocchi, and
G Ragona, and
C Piga, and
A Pelosio, and
A Volpi, and
S Vella, and
N Legniti, and
A de Felici
April 2015,
Vaccines,
G Rocchi, and
G Ragona, and
C Piga, and
A Pelosio, and
A Volpi, and
S Vella, and
N Legniti, and
A de Felici
March 2017,
Archives de pediatrie : organe officiel de la Societe francaise de pediatrie,
G Rocchi, and
G Ragona, and
C Piga, and
A Pelosio, and
A Volpi, and
S Vella, and
N Legniti, and
A de Felici
January 2004,
Scandinavian journal of immunology,
G Rocchi, and
G Ragona, and
C Piga, and
A Pelosio, and
A Volpi, and
S Vella, and
N Legniti, and
A de Felici
February 2015,
The Journal of infectious diseases,
G Rocchi, and
G Ragona, and
C Piga, and
A Pelosio, and
A Volpi, and
S Vella, and
N Legniti, and
A de Felici
May 1979,
The New England journal of medicine,
G Rocchi, and
G Ragona, and
C Piga, and
A Pelosio, and
A Volpi, and
S Vella, and
N Legniti, and
A de Felici
September 2009,
The New England journal of medicine,
G Rocchi, and
G Ragona, and
C Piga, and
A Pelosio, and
A Volpi, and
S Vella, and
N Legniti, and
A de Felici
January 1991,
Veterinary microbiology,
G Rocchi, and
G Ragona, and
C Piga, and
A Pelosio, and
A Volpi, and
S Vella, and
N Legniti, and
A de Felici
September 1989,
Zentralblatt fur Veterinarmedizin. Reihe B. Journal of veterinary medicine. Series B,
G Rocchi, and
G Ragona, and
C Piga, and
A Pelosio, and
A Volpi, and
S Vella, and
N Legniti, and
A de Felici
December 2006,
The New England journal of medicine,
G Rocchi, and
G Ragona, and
C Piga, and
A Pelosio, and
A Volpi, and
S Vella, and
N Legniti, and
A de Felici
February 2009,
Vaccine,
